Rick Lasch Appointed to MSU Research Foundation Board of Directors
Entrepreneur, investor, and MSU alumnus Rick Lasch joins the MSU Research Foundation board, bringing startup experience and a history of supporting the university.
Venture Capital Growth in Greater Lansing Is No Accident — Here’s Who’s Behind It
By David Washburn, Chief Executive Officer, MSU Research Foundation VIEWPOINT — [...]
State of the Region Report Highlights MSU Research Foundation Role in Startup and Innovation Growth
A decade of ecosystem-building by MSU, the Foundation, and regional partners is helping position Greater Lansing as a competitive hub for innovation and entrepreneurship.
$2.2M Transformation Brings New Capabilities to MSU’s Mass Spectrometry and Metabolomics Core
With support from the MSU Research Foundation, the upgraded Core is helping MSU researchers pursue complex, cross-disciplinary challenges.
Engineering the Future of Quantum Computing with EeroQ
In this episode, we talk with Nick Farina and Dr. Johannes Pollanen of EeroQ, a quantum computing startup with roots at Michigan State University.
MSU Announces New Provost and Executive Vice President for Academic Affairs
Laura Lee McIntyre will join MSU as provost and MSU Research Foundation Professor, bringing experience in education, behavioral health, and university leadership to help guide the university’s academic mission and research priorities.
MSU Research Foundation Launches Statewide Jobs Board for Startup Talent
New platform showcases the growth of the Foundation’s startup portfolio, provides a curated path into Michigan’s innovation ecosystem, and supports long-term talent retention across the state.
MSU Research Foundation Designates $75M to Propel Michigan State’s Vision for a Far Better World
The nonprofit foundation’s $75 million designation to the campaign reinforces its decades-long partnership with Michigan State University, advancing research, innovation, and student success through strategic funding over the next eight years.
NK Cell Therapy Could Bring Advanced Cancer Treatment to Community Clinics
Indapta Therapeutics reports 90%+ tumor marker reduction in early trials—without the dangerous side effects of CAR T-cell therapies.
How Natural Killer (NK) Cells Are Advancing Cancer Treatment
Dr. Mark Frohlich never set out to build a lean [...]
